Registered entities
UroGen Pharma Ltd
Reg. No. 4365405Israel
Innovation
24 patent families (17 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 510 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 4 |
Social engagement
Social engagement: 15.7K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
14 investors on record; lead investors include Sonostar Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 57% |
| Private equity | 3 | 21% |
| Other / undisclosed | 3 | 21% |
Recent activity
29 Jun 2026
Leadership hire
General Counsel and Chief Compliance Officer
8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
27 May 2026
Leadership hire
leadership